SABCS 2023 | Highlights from SABCS 2023

Jason Aboudi Mouabbi, MD, from the University of Texas MD Anderson Cancer Center, shares insights from the San Antonio Breast Cancer Symposium (SABCS), describing it as an essential event for breast oncologists globally. The symposium provides updates on existing data, long-term follow-ups for patient reassurance, and introduces novel agents and study results. Prof. Mouabbi highlights a significant study focusing on the possibility of omitting radiation therapy in patients who initially had positive lymph nodes but became node-negative after neoadjuvant chemotherapy. This study aims to explore the potential for de-escalation in nodal radiation. The interview took place at the SABCS congress in San Antonio, TX.

These works are owned by Magdalen Medical Publishing, protected by global copyright laws. All rights are reserved.